These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25304094)

  • 21. Development of 400 microm pellets by extrusion-spheronization: application with Gelucire 50/02 to produce a "sprinkle" form.
    Flament MP; Dupont G; Leterme P; Farah N; Gayot A
    Drug Dev Ind Pharm; 2004 Jan; 30(1):43-51. PubMed ID: 15000429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into the pelletization mechanism by extrusion/spheronization.
    Koester M; Thommes M
    AAPS PharmSciTech; 2010 Dec; 11(4):1549-51. PubMed ID: 21042960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agglomeration tendency in dry pharmaceutical granular systems.
    Lachiver ED; Abatzoglou N; Cartilier L; Simard JS
    Eur J Pharm Biopharm; 2006 Oct; 64(2):193-9. PubMed ID: 16797949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Importance of particle size decrease in the preformulation].
    Szunyogh T; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2011; 81(1):29-36. PubMed ID: 21595303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Online monitoring of particle mass flow rate in bottom spray fluid bed coating--development and application.
    Wang LK; Heng PW; Liew CV
    Int J Pharm; 2010 Aug; 395(1-2):215-21. PubMed ID: 20594985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic modelling of fluidized bed drying processes of wet porous granules: a review.
    Mortier ST; De Beer T; Gernaey KV; Remon JP; Vervaet C; Nopens I
    Eur J Pharm Biopharm; 2011 Oct; 79(2):205-25. PubMed ID: 21664970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Force control and powder dispersibility of spray dried particles for inhalation.
    Weiler C; Egen M; Trunk M; Langguth P
    J Pharm Sci; 2010 Jan; 99(1):303-16. PubMed ID: 19533606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on the formulation and process of Da Chuan Xiong Fang pellet by extrusion-spheronization].
    Hong YL; Feng Y; Xu DS; Jiang LH; Yang Y
    Zhong Yao Cai; 2007 Dec; 30(12):1596-600. PubMed ID: 18422197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparing of pellets by extrusion/spheronization using different types of equipment and process conditions.
    Bölcskei É; Regdon G; Sovány T; Ghanam D; Knop K; Kleinebudde P; Pintye-Hódi K
    Drug Dev Ind Pharm; 2014 Jun; 40(6):762-4. PubMed ID: 23596971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. II. Sphere characteristics.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):413-22. PubMed ID: 9876603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate.
    Kondo K; Ito N; Niwa T; Danjo K
    Int J Pharm; 2013 Sep; 453(2):523-32. PubMed ID: 23796831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melt pelletisation of a hygroscopic drug in a high shear mixer. Part 1. Influence of process variables.
    Thies R; Kleinebudde P
    Int J Pharm; 1999 Oct; 188(2):131-43. PubMed ID: 10518669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V-blender segregation patterns for free-flowing materials: effects of blender capacity and fill level.
    Alexander A; Shinbrot T; Johnson B; Muzzio FJ
    Int J Pharm; 2004 Jan; 269(1):19-28. PubMed ID: 14698573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melt pelletization with polyethylene glycol in a rotary processor.
    Vilhelmsen T; Kristensen J; Schaefer T
    Int J Pharm; 2004 May; 275(1-2):141-53. PubMed ID: 15081145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
    Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
    Int J Pharm; 2010 Mar; 388(1-2):64-72. PubMed ID: 20035851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of starch-based pellets by hot-melt extrusion.
    Bialleck S; Rein H
    Eur J Pharm Biopharm; 2011 Oct; 79(2):440-8. PubMed ID: 21570466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
    Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
    Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistics of particle velocities in dense granular flows.
    Moka S; Nott PR
    Phys Rev Lett; 2005 Aug; 95(6):068003. PubMed ID: 16090994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the formulation parameters on the characteristics of pellets.
    Fekete R; Zelkó R; Marton S; Rácz I
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1073-6. PubMed ID: 9876562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.